American Society for Clinical Pharmacology & Therapeutics (ASCPT) Annual Meeting (Virtual)

Mar 8 - Mar 17, 2021

March 8-12 and 15-17, 2021
  • Bempedoic Acid, a First-in-Class Adenosine Triphosphate (ATP) Citrate Lyase Inhibitor, Is a Human Organic Anion Transporter 2 (OAT2) Inhibitor
  • The Effects of Impaired Hepatic Function on Pharmacokinetics of Bempedoic Acid, a First-in-Class ATP Citrate Lyase Inhibitor, Evaluated in an Open-Label, Single-Dose, Parallel-Group Study